Androgenetic Alopecia (Pattern Baldness) This is the most common form of hair loss, affecting roughly 50% of men by age 50 and a significant percentage of women
Competitive Landscape of Obesity GLP-1 Market The global GLP-1 and obesity drug landscape is entering a transformative phase as patent protections for semaglutide near expiry in key markets such as India and China by 2026
It's an exciting time to practice obesity medicine, and many of my patients have had transformative outcomes because of these medicines
Eating foods high in calcium (such as milk, tuna, salmon, eggs and dark leafy greens) is a good idea, but additional supplementation may be necessary to prevent or slow bone loss
They are used to treat more severe cases of IBD and to end acute attacks
Safety Guardrails and Who Should Avoid Fasting on GLP-1 Patients with Type 1 or Type 2 diabetes, a history of eating disorders, cardiovascular disease, or those taking additional glucose-lowering medications should consult their provider before any fasting protocol on GLP-1 therapy